Tirzepatide treatment results in successful weight loss regardless of obesity-related complications

FHS
June 3, 2024
4:18 pm

Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

COVID-19 vaccines reduce infection and complications in pregnant women

The reactogenicity and impact of coronavirus disease 2019 (COVID-19) vaccines on pregnancy outcomes.

June 18, 2024

Women-Specific Goalposts Urged for Coronary Bypass Surgery

Gender disparities in outcomes after coronary artery bypass grafting (CABG) might be addressed by sex-specific biomarker thresholds for perioperative myocardial injury, researchers suggested from a

July 6, 2024

Pregnant and addicted: Homeless women see hope in street medicine

Five days after giving birth, Melissa Crespo was already back on the streets, recovering in a damp, litter-strewn water tunnel, when she got the call

October 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.